Central Nervous System Pharmacology Practice Questions

Q: What is the preferred initial treatment for a patient diagnosed with Parkinson's disease who is under 65 years old and has minimal symptoms?

Dopamine agonists. ***Dopamine agonists*** - For **younger patients** (under 65) with mild Parkinson's symptoms, dopamine agonists are often preferred as initial therapy. - They tend to cause fewer motor complications compared to levodopa, delaying the onset of **dyskinesias** for several years. *Levodopa* - While highly effective, **levodopa** is typically reserved for older patients or those with more advanced symptoms due to the increased risk of **motor fluctuations** and **dyskinesias** with long-term use, especially in younger individuals. - It is the most potent symptomatic treatment for Parkinson's disease, but its long-term side effects are a concern for younger patients. *MAO-B inhibitors* - **MAO-B inhibitors** are often used as monotherapy for very mild symptoms or as an adjunct therapy to reduce the "off" time in patients already on levodopa. - They provide only modest symptomatic benefit and do not typically offer the same level of symptom control as dopamine agonists or levodopa in initial treatment. *Anticholinergics* - **Anticholinergics** are primarily used to manage **tremor** in younger patients with Parkinson's disease. - They are associated with significant side effects such as cognitive impairment, dry mouth, and constipation, making them less suitable as an initial broad-spectrum treatment, especially in older patients.

Q: A patient on donepezil for Alzheimer's disease begins to experience bradycardia. What is the likely mechanism of this side effect?

Inhibition of acetylcholinesterase. ***Inhibition of acetylcholinesterase*** - Donepezil is an **acetylcholinesterase inhibitor**, meaning it increases the amount of **acetylcholine** in the synaptic cleft. - Increased acetylcholine activity at muscarinic receptors in the heart, particularly **M2 receptors**, leads to **bradycardia** by decreasing the heart rate and conduction velocity. *Increased GABAergic transmission* - **GABA** (gamma-aminobutyric acid) is the primary inhibitory neurotransmitter in the central nervous system and primarily affects neuronal excitability, not directly cardiac rhythm. - Medications that increase GABAergic transmission typically cause **sedation** or **anxiolysis**, and are not directly associated with bradycardia as a primary mechanism. *Blockade of NMDA receptors* - **NMDA receptor blockers** (e.g., memantine) are used in Alzheimer's disease to modulate glutamate activity, but they do not directly influence the cholinergic system or heart rate in a way that causes bradycardia. - Their primary effects are on neuronal excitability and neuroprotection, rather than autonomic cardiac function. *Increased dopamine release* - **Dopamine** acts on alpha, beta, and dopaminergic receptors; its release generally tends to **increase heart rate** and cardiac contractility rather than cause bradycardia. - Increased dopamine is not a mechanism of action for donepezil, which specifically targets acetylcholine.

Q: Which of the following antiepileptic drugs is preferred for treating generalized tonic-clonic seizures?

Valproic acid. ***Valproic acid*** - **Valproic acid** is a broad-spectrum antiepileptic drug effective against various seizure types, including **generalized tonic-clonic seizures**. - It is considered the **gold standard** for generalized seizures because it is effective against all types (absence, myoclonic, and tonic-clonic). - It works by increasing GABA levels, blocking voltage-gated sodium channels, and inhibiting T-type calcium channels. *Ethosuximide* - **Ethosuximide** is specifically used for **absence seizures** (petit mal) and is not effective for generalized tonic-clonic seizures. - It primarily acts by blocking **T-type calcium channels** in the thalamus. *Gabapentin* - **Gabapentin** is primarily used for **focal (partial) seizures** and neuropathic pain, not generalized tonic-clonic seizures. - Its mechanism involves modulating the release of neurotransmitters, possibly by binding to the **α2δ subunit of calcium channels**. *Carbamazepine* - **Carbamazepine** is a first-line treatment for **focal (partial) seizures** and is also effective for **generalized tonic-clonic seizures**, though valproic acid is generally preferred for purely generalized seizures. - It works by blocking voltage-gated sodium channels. - It should be **avoided in absence and myoclonic seizures** as it can worsen these seizure types. - Also used for **trigeminal neuralgia**.

Q: Which of the following acetylcholinesterase inhibitors is most commonly prescribed as first-line therapy for mild to moderate Alzheimer's disease due to its once-daily dosing and favorable side effect profile?

Donepezil. ***Donepezil*** - It is frequently chosen as a **first-line agent** for mild to moderate Alzheimer's disease due to its **favorable side effect profile** and **once-daily dosing** [1]. - Its long half-life allows for administration once a day, which can improve **patient adherence** to therapy [1]. *Galantamine* - This acetylcholinesterase inhibitor typically requires **twice-daily dosing**, which is less convenient than donepezil's once-daily regimen [2]. - While effective, it does not hold the same **first-line preference** as donepezil due to its more frequent administration [2]. *Rivastigmine* - Rivastigmine is available in oral and transdermal patch formulations, but its oral form often requires **twice-daily dosing** or more [2]. - Its side effect profile can be more pronounced, particularly **gastrointestinal side effects**, compared to donepezil [2]. *All of the options* - While all listed options are acetylcholinesterase inhibitors used in Alzheimer's disease, **Donepezil** stands out as the most common first-line choice due to its once-daily dosing and well-tolerated profile [1], [2]. - The other options have different dosing schedules or side effect profiles that make them less universally preferred as initial therapy [2].

Q: What is the first-line treatment for a patient presenting with an acute dystonic reaction?

Anticholinergics. ***Anticholinergics*** - **Anticholinergic medications**, such as **benztropine** or **diphenhydramine**, are the **first-line treatment** for acute dystonic reactions. - They work by **blocking muscarinic acetylcholine receptors**, thereby re-establishing the balance between dopamine and acetylcholine in the basal ganglia, which is disrupted in dystonia. *Benzodiazepines* - While benzodiazepines can provide some symptomatic relief by reducing muscle spasms and anxiety, they are **not the first-line treatment** for the underlying neurological cause of acute dystonia. - They primarily act on **GABA receptors**, promoting muscle relaxation, but do not directly address the dopamine-acetylcholine imbalance. *Beta-blockers* - **Beta-blockers** are primarily used to treat conditions like **hypertension**, **anxiety**, or **essential tremor**, and are **not effective** for acute dystonic reactions. - They work by blocking beta-adrenergic receptors and have no direct role in the pathophysiology of dystonia. *Dopamine agonists* - **Dopamine agonists** are typically used to **increase dopamine activity**, as seen in conditions like **Parkinson's disease**. - Acute dystonic reactions are often caused by **dopamine receptor blockade** (e.g., by antipsychotics), so increasing dopamine agonism would generally be **contraindicated** or ineffective.

Q: A 28-year-old woman with a history of seizures is prescribed a classic anticonvulsant that primarily works by inhibiting voltage-gated sodium channels. Which drug is most likely being prescribed?

Phenytoin. ***Phenytoin*** - **Phenytoin** is the **classic prototype anticonvulsant** [1] that primarily works by **blocking voltage-gated sodium channels**, thus stabilizing the neuronal membrane and preventing repetitive firing [2]. - It is effective in treating various seizure types, including **focal** and **generalized tonic-clonic seizures** [1]. - As the traditional first-line agent in this class, it is the most likely answer when referring to a "classic" sodium channel blocker [1]. *Carbamazepine* - While **carbamazepine** also works by **blocking voltage-gated sodium channels** [2], it is structurally related to tricyclic antidepressants and came after phenytoin. - It's often used for **focal seizures** and **trigeminal neuralgia**. - Considered an important alternative but not the "classic" prototype [1]. *Valproate* - **Valproate** has **multiple mechanisms of action**, including inhibiting **GABA transaminase** (increasing GABA levels), blocking **sodium channels**, and modulating **T-type calcium channels** [2]. - Its broad spectrum is useful for both **focal** and **generalized seizures**, including absence seizures. - Not primarily classified as a sodium channel blocker due to its multiple mechanisms. *Lamotrigine* - **Lamotrigine** is a **newer anticonvulsant** [1] that inhibits presynaptic **voltage-gated sodium channels**, reducing the release of excitatory neurotransmitters like glutamate [2]. - It is effective against various seizure types, including **focal**, **generalized tonic-clonic**, and seizures associated with **Lennox-Gastaut syndrome**. - Developed later as a second-generation antiepileptic drug [1].

Q: A patient with Parkinson's disease is given a dopamine agonist to manage motor symptoms by directly stimulating dopamine receptors. Which drug corresponds to this description?

Pramipexole. ***Pramipexole*** - **Pramipexole** is a commonly used **non-ergot dopamine agonist** that **directly stimulates dopamine D2 and D3 receptors** in the brain. - It is effective in managing motor symptoms of **Parkinson's disease** by mimicking the effects of dopamine, particularly in early-stage disease or as an adjunct to levodopa. - Unlike levodopa, it does not require enzymatic conversion and directly activates dopamine receptors. *Levodopa* - **Levodopa** is a **dopamine precursor** that is converted into dopamine in the brain via aromatic L-amino acid decarboxylase (AADC). - It works by **replenishing deficient dopamine levels** rather than directly stimulating dopamine receptors. - It is the most effective symptomatic treatment for Parkinson's disease but is **not a dopamine agonist**. *Selegiline* - **Selegiline** is a **selective monoamine oxidase-B (MAO-B) inhibitor** that prevents the breakdown of dopamine in the brain. - It **increases dopamine availability** by blocking its metabolism but does not directly stimulate dopamine receptors. - It is used as an adjunct therapy to enhance the effects of endogenous or exogenous dopamine. *Entacapone* - **Entacapone** is a **catechol-O-methyltransferase (COMT) inhibitor** that prevents the peripheral breakdown of levodopa. - This action **prolongs the half-life of levodopa**, allowing more to cross the blood-brain barrier, but it does not directly stimulate dopamine receptors. - It is always used in combination with levodopa/carbidopa to enhance levodopa's effectiveness.

Q: What is the first-line drug for the prophylaxis of cluster headaches?

Verapamil. ***Verapamil*** - **Verapamil**, a **non-dihydropyridine calcium channel blocker**, is the **first-line prophylactic agent** for chronic cluster headaches due to its efficacy in reducing headache frequency and severity. - It works by **stabilizing neuronal excitability** and has a **better safety profile** for long-term use compared to acute treatments. *Sumatriptan* - **Sumatriptan** is an **abortive therapy** used for the acute treatment of cluster headache attacks, not for long-term prophylaxis. - It acts as a **serotonin 5-HT1B/1D receptor agonist** to constrict cranial blood vessels and inhibit pain pathways. *Prednisone* - **Prednisone**, a corticosteroid, can be used as a **short-term bridge therapy** to provide rapid relief during the initiation of a long-term prophylactic agent but is not suitable for routine chronic prophylaxis due to significant side effects. - Its mechanism involves **reducing inflammation**, which can temporarily alleviate headache symptoms. *Lithium* - **Lithium** is an **alternative prophylactic agent** for cluster headaches, particularly effective in **chronic cluster headache** that is refractory to verapamil. - It is considered **second-line** due to its narrow therapeutic index and the need for regular blood level monitoring.

Q: A 35-year-old male is prescribed morphine for severe pain. What is a common side effect of morphine?

Sedation. ***Sedation*** - **Morphine** is an **opioid analgesic** that acts on **central nervous system** opioid receptors, leading to a depressant effect, which manifests as sedation. - This side effect is due to its action on the **brainstem**, affecting various physiological functions including wakefulness. *Hypertension* - **Morphine** typically causes **hypotension** rather than hypertension due to its **vasodilatory effects**. - It can release **histamine**, which contributes to vasodilation and a drop in blood pressure. *Diarrhea* - **Morphine** is well-known for causing **constipation** by decreasing **gastrointestinal motility** and increasing anal sphincter tone. - It increases **non-propulsive contractions** and reduces **propulsive contractions** in the gut, leading to stool retention. *Polyuria* - **Morphine** can actually cause **oliguria** or **urinary retention** due to increased **antidiuretic hormone (ADH) secretion** and contraction of the **bladder sphincter**. - It affects the **renal system** by altering hormonal regulation and smooth muscle tone, not by increasing urine output.

Q: Which antiepileptic drug is used for neuropathic pain and works by inhibiting voltage-gated calcium channels?

Gabapentin. ***Gabapentin*** - **Gabapentin** is a commonly used antiepileptic drug that primarily acts by binding to the **alpha-2-delta subunit of voltage-gated calcium channels**, reducing calcium influx and subsequent neurotransmitter release. - This mechanism is particularly effective in treating **neuropathic pain**, such as diabetic neuropathy and postherpetic neuralgia. *Carbamazepine* - **Carbamazepine** works primarily by blocking **voltage-gated sodium channels**, thereby stabilizing neuronal membranes and inhibiting repetitive neuronal firing. - While effective for certain types of pain, like **trigeminal neuralgia**, its primary mechanism and widespread use for general neuropathic pain differ from gabapentin. *Levetiracetam* - **Levetiracetam's** precise mechanism of action is not fully understood, but it is thought to involve binding to the **synaptic vesicle protein 2A (SV2A)**, modulating neurotransmitter release. - It is primarily used as an antiepileptic for various seizure types and is generally **not a first-line treatment for neuropathic pain**. *Lamotrigine* - **Lamotrigine** works by blocking **voltage-gated sodium channels** and, to a lesser extent, **calcium channels**, thereby stabilizing neuronal membranes and inhibiting excitatory neurotransmitter release. - While it has some efficacy in neuropathic pain, its primary mechanism and therapeutic profile are distinct from gabapentin's selective action on voltage-gated calcium channels.

Question 1

What is the preferred initial treatment for a patient diagnosed with Parkinson's disease who is under 65 years old and has minimal symptoms?

Accepted Answer

Dopamine agonists

Answer

Levodopa

Answer

MAO-B inhibitors

Answer

Anticholinergics

Question 2

A patient on donepezil for Alzheimer's disease begins to experience bradycardia. What is the likely mechanism of this side effect?

Accepted Answer

Inhibition of acetylcholinesterase

Answer

Increased GABAergic transmission

Answer

Blockade of NMDA receptors

Answer

Increased dopamine release

Question 3

Which of the following antiepileptic drugs is preferred for treating generalized tonic-clonic seizures?

Accepted Answer

Valproic acid

Answer

Ethosuximide

Answer

Gabapentin

Answer

Carbamazepine

Question 4

Which of the following acetylcholinesterase inhibitors is most commonly prescribed as first-line therapy for mild to moderate Alzheimer's disease due to its once-daily dosing and favorable side effect profile?

Accepted Answer

Donepezil

Answer

Galantamine

Answer

Rivastigmine

Answer

All of the options

Question 5

What is the first-line treatment for a patient presenting with an acute dystonic reaction?

Accepted Answer

Anticholinergics

Answer

Benzodiazepines

Answer

Beta-blockers

Answer

Dopamine agonists

Question 6

A 28-year-old woman with a history of seizures is prescribed a classic anticonvulsant that primarily works by inhibiting voltage-gated sodium channels. Which drug is most likely being prescribed?

Accepted Answer

Phenytoin

Answer

Valproate

Answer

Carbamazepine

Answer

Lamotrigine

Question 7

A patient with Parkinson's disease is given a dopamine agonist to manage motor symptoms by directly stimulating dopamine receptors. Which drug corresponds to this description?

Accepted Answer

Pramipexole

Answer

Levodopa

Answer

Selegiline

Answer

Entacapone

Question 8

What is the first-line drug for the prophylaxis of cluster headaches?

Accepted Answer

Verapamil

Answer

Sumatriptan

Answer

Prednisone

Answer

Lithium

Question 9

A 35-year-old male is prescribed morphine for severe pain. What is a common side effect of morphine?

Accepted Answer

Sedation

Answer

Hypertension

Answer

Diarrhea

Answer

Polyuria

Question 10

Which antiepileptic drug is used for neuropathic pain and works by inhibiting voltage-gated calcium channels?

Accepted Answer

Gabapentin

Answer

Carbamazepine

Answer

Levetiracetam

Answer

Lamotrigine

Central Nervous System Pharmacology — MCQs

Central Nervous System Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?